Find the latest pharmaceutical market place for formulations enquiry about Nelarabine on PharmaCompass.com.

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various Finished Dosage Formulations needed in Turkey [ENA12951]

A company that deals in urology, women's health, oncology and rare diseases and offers innovative treatments and ground-breaking genetic technologies is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with PIC/S, GMP and CoA.
1. Nelarabine (250 mg/ 50 ml) Vials. The required quantity is 1,325 units.
2. Naltrexone Hydrochloride (50 mg) Tablets. The required quantity is 45,000 units.
3. Tafamidis (20 mg) Capsules. The required quantity is 400 boxes.
4. Treosulfan (5 g) Vials. The required quantity is 600 units.

Reply

10 Mar 2022

turkeypng-1602828403png-1622460951png-1622462103 Flag

Various Finished Dosage Formulations needed in Turkey [ENA11323]

A company that deals in oncology, urology, women's health and rare diseases and offers innovative treatments and ground-breaking genetic technologies is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with PIC/S, GMP and CoA.
1. Naltrexone Hydrochloride (50 mg) Capsules/ Tablets
2. Nelarabin (250 mg) Ampoules
3. Pegaspargase (3750 IU) Vials
4. Ponatinib (45 mg) Tablets
5. Pralatrexate (20 mg/ ml) Vials
6. Romidepsin (10 mg) Vials

Reply

07 Sep 2021

Nelarabine (250 mg/ 50 ml) Injections needed in Canada [ENA10241]

A company that deals in various pharmaceutical products is looking for suppliers of Nelarabine (250 mg/ 50 ml) Injections.

Reply

16 Apr 2021

PuertoRico Flag

Various Finished Dosage Formulations needed in Puerto Rico [ENA09492]

An international pharmaceutical company that focuses on the commercialization of therapies is looking for suppliers of Various Finished Dosage Formulations for commercial manufacturing purposes. The final market is India.
1. Isoproterenol (0.2 mg/ ml concentration in 1 ml and 5 ml liquid vials) for Injection
2. Palonosetron HCl (0.25 mg in 5 ml liquid vial) for Injection
3. Nelarabine (5 mg/ ml concentration of 250 mg in 5 ml liquid vial) for Injection
4. Lanreotide (120 mg in 0.5 ml Prefilled Syringe) for Injection
5. Zoledronic acid (0.8 mg/ ml concentration of 5 mg in 100 ml liquid vial) for Injection

Reply

14 Jan 2021